Yang Luke Chen Sells 44,000 Shares of 111 (NASDAQ:YI) Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 44,000 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $0.23, for a total value of $10,120.00. Following the sale, the director directly owned 495,462 shares in the company, valued at $113,956.26. This trade represents a 8.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Friday, June 12th, Yang Luke Chen sold 49,920 shares of 111 stock. The shares were sold at an average price of $0.23, for a total value of $11,481.60.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The shares were sold at an average price of $0.25, for a total value of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The shares were sold at an average price of $0.27, for a total value of $388.80.

111 Price Performance

111 stock opened at $4.57 on Tuesday. The stock has a market capitalization of $40.17 million, a PE ratio of -3.26 and a beta of 0.60. The business’s fifty day moving average is $5.88 and its 200 day moving average is $5.66. 111, Inc. Sponsored ADR has a one year low of $2.48 and a one year high of $11.17.

Analyst Ratings Changes

Separately, Weiss Ratings cut 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, 111 has an average rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.